PeptideDB

DL-Pyroglutamic acid 149-87-1

DL-Pyroglutamic acid 149-87-1

CAS No.: 149-87-1

DL-Pyroglutamic acid, as a hepatitis B surface inactivator, can inactivate vaccinia virus, herpes simplex virus and infl
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

DL-Pyroglutamic acid, as a hepatitis B surface inactivator, can inactivate vaccinia virus, herpes simplex virus and influenza virus in addition to poliovirus. DL-Pyroglutamic acid is also a possible aminobutyric acid (GABA) aminotransferase inhibitor, increases GABA content and has anti-epileptic effects.

Physicochemical Properties


Molecular Formula C5H7NO3
Molecular Weight 129.11
Exact Mass 129.042
CAS # 149-87-1
Related CAS # DL-Pyroglutamic acid-d5;352431-30-2
PubChem CID 499
Appearance White to off-white solid powder
Density 1.4±0.1 g/cm3
Boiling Point 453.1±38.0 °C at 760 mmHg
Melting Point 180-185ºC
Flash Point 227.8±26.8 °C
Vapour Pressure 0.0±2.4 mmHg at 25°C
Index of Refraction 1.512
LogP -2.39
Hydrogen Bond Donor Count 2
Hydrogen Bond Acceptor Count 3
Rotatable Bond Count 1
Heavy Atom Count 9
Complexity 154
Defined Atom Stereocenter Count 0
InChi Key ODHCTXKNWHHXJC-UHFFFAOYSA-N
InChi Code

InChI=1S/C5H7NO3/c7-4-2-1-3(6-4)5(8)9/h3H,1-2H2,(H,6,7)(H,8,9)
Chemical Name

5-oxopyrrolidine-2-carboxylic acid
HS Tariff Code 2934.99.9001
Storage

Powder-20°C 3 years

4°C 2 years

In solvent -80°C 6 months

-20°C 1 month

Shipping Condition Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity


ln Vitro DL-Pyroglutamic acid results 50 and 100%, respectively, inactivation of the antigen at 0.01-0.025% and 0.025-0.05%[1]. According to Druce and Bradford, DL-pyroglutamic acid may be a glutamate antagonist since it inhibits the glutamate miniature-end-plate potential in locust muscle [2].
ln Vivo DL-Pyroglutamic acid (0.775 mM/L) cobalt implantation in the sensorimotor cerebral cortex completely eliminates the myoclonic jerks and EEG spikes in rats model of epilepsy[2].
References

[1]. N-alpha-Cocoyl-L-arginine ethyl ester, DL-pyroglutamic acid salt, as an inactivator of hepatitis B surface antigen. Antimicrob Agents Chemother. 1979 Sep;16(3):329-32.

Additional Infomation 5-oxoproline is an oxoproline having the oxo group placed at the 5-position. It is an intermediate metabolite in the glutathione cycle. It has a role as a human metabolite. It is a pyrrolidinemonocarboxylic acid, a member of pyrrolidin-2-ones and an oxoproline. It is a conjugate acid of a 5-oxoprolinate.
DL-Pyroglutamic acid has been reported in Drosophila melanogaster, Mycoplasma gallisepticum, and other organisms with data available.
A cyclized derivative of L-GLUTAMIC ACID. Elevated blood levels may be associated with problems of GLUTAMINE or GLUTATHIONE metabolism.

Solubility Data


Solubility (In Vitro) DMSO : 100 mg/mL (774.53 mM)
Solubility (In Vivo) Solubility in Formulation 1: ≥ 2.5 mg/mL (19.36 mM) (saturation unknown) in 10% DMSO + 40% PEG300 +5% Tween-80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 + to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL.
Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution.

 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 7.7453 mL 38.7267 mL 77.4533 mL
5 mM 1.5491 mL 7.7453 mL 15.4907 mL
10 mM 0.7745 mL 3.8727 mL 7.7453 mL
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.